Preparation and characteristics of hydroxypropyl-β-cyclodextrin polymeric nanocapsules loading nimodipine

被引:41
作者
Du, Yong-Zhong [1 ]
Xu, Jia-Guo [1 ]
Wang, Ling [1 ]
Yuan, Hong [1 ]
Hu, Fu-Qiang [1 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China
关键词
Hydroxypropyl-beta-cyclodextrin; Polymeric nanocapsules; Nimodipine; Polyaddition; In vitro drug release; PHARMACEUTICAL APPLICATION; INCLUSION COMPLEXES; NANOPARTICLES; PHOTODEGRADATION; MICROSPHERES; ALPHA;
D O I
10.1016/j.eurpolymj.2009.01.031
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 [高分子化学与物理];
摘要
Nimodipine loaded hydroxypropyl-beta-cyclodextrin polymeric nanocapsules were prepared by interfacial polyaddition of hydroxypropyl-beta-cyclodextrin and isophorone diisocyante in a miniemulsion system. The effects of ultrasonicate times on the preparation of miniemulsion, the total amount of hydroxypropyl-beta-cyclodextrin and isophorone diisocyante, and the molar ratio of isophorone diisocyante to hydroxypropyl-beta-cyclodextrin on the capsule size and drug release behavior from capsule were investigated. The chitosan based polymeric nanocapsules were prepared as a control to study the effect of hydroxypropyl-beta-cyclodextrin molecules in capsule matrix on the drug release. The results indicated that the droplet size of miniemulsion and capsule size decreased with increasing sonicate times. When the total amount of hydroxypropyl-beta-cyclodextrin and isophorone diisocyante and, the molar ratio of isophorone diisocyante to hydroxypropyl-beta-cyclodextrin were increased, the capsule as well, but the drug release rates from capsules became slower. The drug release behaviors from hydroxypropyl-beta-cyclodextrin polymeric nanocapsules were affected by the drug diffusion through the polymer matrix and the formation of inclusion complex between drug and hydroxypropyl-beta-cyclodextrin. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1397 / 1402
页数:6
相关论文
共 21 条
[1]
High molecular weight polyurethane and polymer hybrid particles in aqueous miniemulsion [J].
Barrère, M ;
Landfester, K .
MACROMOLECULES, 2003, 36 (14) :5119-5125
[2]
Preparation and characterisation of poly(vinyl alcohol)/cyclodextrin microspheres as matrix for inclusion and separation of drugs [J].
Constantin, M ;
Fundueanu, G ;
Bortolotti, F ;
Cortesi, R ;
Ascenzi, P ;
Menegatti, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 285 (1-2) :87-96
[3]
Effects of conditions for preparing nanoparticles composed of aminoethylcarbamoyl-β-cyclodextrin and ethylene glycol diglycidyl ether on trap efficiency of a guest molecule [J].
Eguchi, M ;
Du, YZ ;
Ogawa, Y ;
Okada, T ;
Yumoto, N ;
Kodaka, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 311 (1-2) :215-222
[4]
Eguchi M., 2005, NANOBIOTECHNOLOGY, V1, P165
[5]
Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy®) in allergic rhinitis treatment [J].
Fundueanu, G ;
Constantin, M ;
Dalpiaz, A ;
Bortolotti, F ;
Cortesi, R ;
Ascenzi, P ;
Menegatti, E .
BIOMATERIALS, 2004, 25 (01) :159-170
[6]
Conjugates of poly(DL-lactic acid) with ethylenediamino or diethylenetriamino bridged bis(β-cyclodextrin)s and their nanoparticles as protein delivery systems [J].
Gao, Hui ;
Yang, Ying-wei ;
Fan, Yun-ge ;
Ma, Jian-biao .
JOURNAL OF CONTROLLED RELEASE, 2006, 112 (03) :301-311
[7]
PREPARATION OF IMMOBILIZED BETA-CYCLODEXTRINS BY USE OF ALKANEDIOL DIGLYCIDYL ETHERS AS CROSS-LINKING AGENTS AND THEIR GUEST BINDING ABILITIES [J].
KOMIYAMA, M ;
HIRAI, H .
POLYMER JOURNAL, 1987, 19 (06) :773-775
[8]
Solubility study of nimodipine inclusion complexation with α- and β-cyclodextrin and some substituted cyclodextrins [J].
Kopecky, F ;
Kopecká, B ;
Kaclík, P .
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2001, 39 (3-4) :215-217
[9]
A new drug nanocarrier consisting of chitosan and hydoxypropyleyclodextrin [J].
Maestrelli, Francesca ;
Garcia-Fuentes, Marcos ;
Mura, Paola ;
Alonso, Maria Jose .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 63 (02) :79-86
[10]
MEMISOGLU E, 2002, EUR J PHARM SCI, V17, pS81